Advertisement
  • Forward Look

    A Diabetes Drug for Cancer?

    Lab results spur researchers to test low-cost medication on humans.

    by Stephen Ornes

  • Forward Look

    Cancer Screening: A Dose of Reality

    Q&A with H. Gilbert Welch, professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice.

    by Sue Rochman

  • Forward Look

    When Is “Cancer” Not Cancer?

    Does the word “cancer” discourage patients with very early disease from fully considering all their options?

    by Stephen Ornes

  • Forward Look

    The Avastin Roller Coaster

    Ups and downs keep coming for Avastin as studies report on its effects for different cancers.

    by Sue Rochman

  • Clinical Trials Game-Changer?

    A new type of clinical trial aims to identify which drug is the best fit for each patient's tumor. Can this innovative model expedite new drug approvals?

    by Sue Rochman

  • Cancer In America

    Standard of Care

    Research suggests that black patients, as a whole, aren't receiving the same level of treatment as white patients. Can building better bonds between doctors and patients help?

    by Charlotte Huff

  • The HPV Cancer Connection: Take 2

    New insights about HPV's role in multiple cancers are rapidly expanding, as are thoughts about who should be vaccinated against the virus, and why.

    by Alanna Kennedy-Gorman

  • Healthy Habits

    Just Another Meatless Monday

    Make room for tasty vegetarian dishes in your weekly menu.

    by Alanna Kennedy-Gorman

  • Staying the Course

    Patients are increasingly skipping treatment breaks and opting for ongoing treatment known as maintenance therapy to try to keep some types of cancer at bay.

    by Melissa Weber

  • The Birth of a Targeted Therapy

    A serendiptious discovery more than 50 years ago heralded a new age of cancer treatment.

    by Jocelyn Selim